Cargando…
Cholinesterase is Associated With Prognosis and Response to Chemotherapy in Advanced Gastric Cancer
Background: Cholinesterase (CHE) is a routine serum biomarker in gastric cancer (GC). However, little research has been done on its clinical value in advanced GC. In addition, it is not clear whether it can be used as biomarker for the response and prognosis of advanced GC patients. Methods: Between...
Autores principales: | Bi, Yanzhi, Zhang, Junling, Zeng, Dongxiang, Chen, Lili, Ye, Wei, Yang, Quanliang, Ling, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262142/ https://www.ncbi.nlm.nih.gov/pubmed/34257526 http://dx.doi.org/10.3389/pore.2021.580800 |
Ejemplares similares
-
High GP73 Expression Correlates with Poor Response to Neoadjuvant Chemotherapy and Survival in Gastric Cancer: A Tissue Microarray Study
por: Shen, Jian Guo, et al.
Publicado: (2021) -
Identification of miRNA Signature in Breast Cancer to Predict Neoadjuvant Chemotherapy Response
por: Xing, Ai-Yan, et al.
Publicado: (2021) -
Hybrid Capture-based Genomic Profiling of Circulating Tumor DNA From Patients With Advanced Ovarian Cancer
por: Shen, Wenbin, et al.
Publicado: (2021) -
UBE2T Contributes to the Prognosis of Esophageal Squamous Cell Carcinoma
por: Wang, Xiaoyuan, et al.
Publicado: (2021) -
Autophagy Plays a Role in the CUL4A-Related Poor Prognosis of Intrahepatic Cholangiocarcinoma
por: Weng, Shao-Wen, et al.
Publicado: (2021)